However, CD36 was a controversial indicator in pancreatic cancer, low expression of CD36 predicted lower TNM staging and CA19-9 levels, but larger tumor size and poor survival prognosis 28. The gene discussed is CD36; the disease is familial pancreatic carcinoma.